4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-22-000006
Chief Commercial Officer sold 6,857 shares at $17.72 ($121,506)
From the SEC's structured data for this filing
Trades in this filing
Mottiwala Aziz · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-15 | Sale : show line 1 in the form | −6,857 | $17.72 | $121,506 | 49,729 | D |
| Open-market sales · 6,857 sh · avg $17.72 · $121,506 | ||||||
Loading xslF345X03/wf-form4_166872420553318.xml…